Edition:
India

Kaken Pharmaceutical Co Ltd (4521.T)

4521.T on Tokyo Stock Exchange

5,930JPY
21 Sep 2018
Change (% chg)

¥140 (+2.42%)
Prev Close
¥5,790
Open
¥5,830
Day's High
¥5,990
Day's Low
¥5,740
Volume
173,700
Avg. Vol
112,245
52-wk High
¥6,600
52-wk Low
¥5,260

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Underperform -- March 24 Sep 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 2 2 2 2
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 4.00 4.00 4.00 4.00

Consensus Estimates Analysis

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Mar-18 2 99,750.00 100,200.00 99,300.00 --
Year Ending Mar-19 2 93,100.00 93,500.00 92,700.00 97,700.00
Year Ending Mar-20 2 93,100.00 93,200.00 93,000.00 98,650.00
Earnings (per share)
Year Ending Mar-18 2 490.65 491.10 490.20 --
Year Ending Mar-19 2 424.89 433.00 416.78 449.86
Year Ending Mar-20 2 428.49 437.60 419.39 459.76

Historical Surprises

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-13 21,845.00 20,249.00 1,596.00 7.31
Quarter Ending Dec-12 24,290.00 23,282.00 1,008.00 4.15
Quarter Ending Sep-12 22,719.00 22,742.00 23.00 0.10
Quarter Ending Jun-12 21,400.00 20,781.00 619.00 2.89

Consensus Estimates Trend

Sales and Profit Figures in Japanese Yen (JPY)
Earnings and Dividend Figures in Japanese Yen (JPY)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Mar-18 99,750.00 -- -- -- --
Year Ending Mar-19 93,100.00 93,100.00 93,100.00 93,050.00 97,700.00
Year Ending Mar-20 93,100.00 93,100.00 93,100.00 93,100.00 98,650.00

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Mar-18 -- -- -- --
Year Ending Mar-19 0 0 0 0
Year Ending Mar-20 0 0 0 0
Earnings